cA theoCare FEB 03 2003
510(k) Summary
K030108
“ArthroCare Corporation
ArthroCare ENT Coblator Surgery System

General Information
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-2936
Phone Number: (408) 736-0224
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: January 10, 2003
Device Description
Trade Name: ArthroCare ENT Coblator Surgery System
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR 878.4400)
Predicate Devices
irecicate Devices
ENTec” Plasma Wands K021364
Product Description
The ArthroCare ENT Coblator Surgery System is a bipolar, high frequency
electrosurgical system consisting of three components: an electrosurgical generator called
the Controller; a family of disposable, bipolar, single use Wands; and a reusable Patient
Cable.
680 Vaqueros Avenue * Sunnyvale, CA 94085 * (408) 736-0224 © Fax: (408) 736-0226

ix

Intended Uses
The ArthroCare ENT Coblator Surgery System is indicated for ablation, resection, and
coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT)
surgery including:
= Adenoidectomy
= Cysts
= Head, Neck, Oral, and Sinus Surgery
« Mastoidectomy
=" Myringotomy with Effective Hemorrhage Control
= Nasal Airway Obstruction by Reduction of Hypertrophic
Nasal Turbinates
= Nasopharyngeal/Laryngeal indications including
Tracheal Procedures, Laryngeal Polypectomy, and
Laryngeal Lesion Debulking
* Neck Mass
= Papilloma Keloids
= Submucosal Palatal Shrinkage
= Submucosal Tissue Shrinkage
= Tonsillectomy
= Traditional Uvulopalatoplasty (RAUP)
= Tumors
= Tissue in the Uvula/Soft Palate for the Treatment of
Snoring
Substantial Equivalence
This Special 510(k) proposes a modification in the performance specifications,
dimensional specifications, and labeling for the ArthroCare ENT Coblator Plasma
Surgery System, which was previously cleared in K021364 on May 30, 2002. The
indications for use, technology, principle of operation, materials, packaging, and
sterilization parameters of the ArthroCare ENT Coblator Surgery System remain the
same as in the predicate cleared 510(k).
Summary of Safety and Effectiveness
The modified ArthroCare ENT Coblator Surgery System, as described in this Special
510(k), is substantially equivalent to the predicate device. The proposed modifications in
performance specifications, dimensional specifications, and labeling are not substantial
changes or modifications, and do not significantly affect the safety or efficacy of the
System.
x

—_
i & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
& ee SSSSSSSSSSSSSSSSSSSSSSSSSeeeeeeee
“ee Food and Drug Administration
9200 Corporate Boulevard
FEB 0 3 2003 Rockville MD 20850
Arthocare Corporation
Valerie Defiesta-Ng
Director, Regulatory Affairs
680 Vaqueros Avenue
Sunnyvale, California 94085-2936
Re: K030108
Trade/Device Name: Arthrocare ENT Coblator Surgery System
Regulation Number: 878:4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: Class II
Product Code: GEI
Dated: January 10, 2003
Received: January 13, 2003
Dear Ms. Defiesta-Ng: :
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. ‘
If your device is classified (see above) into either class II (Special Controls) or class IH (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing
(21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2~ Ms. Valerie Defiesta-Ng
This letter will allow you to begin marketing your device as described in your Section 510(k)

‘ premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). Other general
information on your responsibilities under the Act may be obtained from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address
http://www. fda.gov/cdrh/dsma/dsmamain. html
Sincerely yours,
_ : t
Mand Free
ferCelia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

Indications for Use Statement
Device Name: = ArthroCare ENT Coblator Surgery System
510(k) Number: K @30/08
Indications for Use:
The ArthroCare ENT Coblator Surgery System is indicated for ablation, resection, and
coagulation of soft tissue and hemostasis of blood vessels in otorhinolaryngology (ENT)
surgery including:
= Adenoidectomy
= Cysts
= Head, Neck, Oral, and Sinus Surgery
= Mastoidectomy
= Myringotomy with Effective Hemorrhage Control
= Nasal Airway Obstruction by Reduction of Hypertrophic
Nasal Turbinates
= Nasopharyngeal/Laryngeal indications including
Tracheal Procedures, Laryngeal Polypectomy, and
Laryngeal Lesion Debulking
= Neck Mass
= Papilloma Keloids
= Submucosal Palatal Shrinkage
= Submucosal Tissue Shrinkage
= Tonsillectomy
= Traditional Uvulopalatoplasty (RAUP)
= Tumors
= Tissue in the Uvula/Soft Palate for the Treatment of
Snoring
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use x OR Over-the-Counter
Use
(Per 21 CFR
801.109)
Yoram 0 Lreveok
_. ovision Sign-Off)
_rvision of Genewal, Restorative
wud Neurological Devices
“8 Murther KO39/08
Vili

